Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Piotr, Stoksik"'
Autor:
Bogusław, Bucki, Renata, Tomaszewska, Halina, Bubała, Danuta, Sońta-Jakimczyk, Jacek, Karpe, Piotr, Stoksik
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 62(2)
Long term disease treatment in children is a very special medical problem due to a necessity of maintaining an efficient venous access for many months and even years. Vascular ports applied in those children improved the conditions of treatment and a
Autor:
Tomasz Szczepański, Renata Tomaszewska, Piotr Stoksik, Danuta Sońta-Jakimczyk, Jacek Karpe, Bogusław Bucki
Publikováno v:
Pediatric hematology and oncology. 25(8)
During past 10 years 234 central venous access ports (CVAP) were implanted in 225 patients at the Department of Pediatric Hematology and Oncology in Zabrze. Mean exposure time was 745 days and total implantation time reached 173,768 days. Complicatio
Autor:
Maria, Szczepańska, Krystyna, Szprynger, Piotr, Stoksik, Aurelia, Morawiec-Knysak, Piotr, Adamczyk, Katarzyna, Ziora, Joanna, Oswiecimska
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 59(11-12)
The application of central venous lines in children has been widely accepted in the case of pediatric cancer treatment. This is of particular importance when the treatment must be continued during the long period of time. The indication to long-term
Autor:
Bogusław, Bucki, Jacek, Karpe, Piotr, Stoksik, Tomasz, Legaszewski, Renata, Tomaszewska, Igor, Olejnik, Jarosław, Rycaj, Zuzanna, Jackowska
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 59(9-10)
Occasionally unexpected technical difficulties occur during Port-A-Cath implantation and the central venous catheterization. We described a case of superior vena cava developmental anomaly diagnosed during Port-A-Cath implantation.
Autor:
Jarosław, Rycaj, Hanna, Misiołek, Piotr, Stoksik, Renata, Tomaszewska, Jacek, Karpe, Jacek, Kaczmarski, Hanna, Kucia, Piotr, Knapik, Tadeusz, Kasza
Publikováno v:
Wiadomosci lekarskie (Warsaw, Poland : 1960). 58(1-2)
The aim of the work was to evaluate the safety of Vascuport catheter long-term application in children treated for acute lymphoblastic leukemia (ALL). 21 children treated in the Department of Pediatric and Hematology in Zabrze were enrolled in the st